AbbVie Inc.
Time frame: 1 May 2023 - 30 April 2024Article ‘Count’ and ‘Share’ for AbbVie Inc. based on listed parameters only.
The articles listed below published by authors from AbbVie Inc., organized by journal and article, represent the research output in Count and Share according to the parameters selected above.
Journal | Count | Share |
---|---|---|
American Journal of Human Genetics |
1 | 0.05 |
Angewandte Chemie International Edition |
1 | 0.25 |
Annals of the Rheumatic Diseases |
1 | 0.36 |
Chemical Communications |
1 | 0.11 |
JAMA Internal Medicine |
1 | 0.23 |
JAMA: The Journal of the American Medical Association |
1 | 0.02 |
Journal of Clinical Endocrinology & Metabolism |
2 | 0.55 |
Journal of Experimental Medicine |
1 | 0.09 |
Journal of Neuroscience |
1 | 0.25 |
Journal of the American Academy of Dermatology |
3 | 1.66 |
Journal of the American Chemical Society |
3 | 1.34 |
Nature |
4 | 0.58 |
Nature Chemistry |
1 | 0.11 |
Nature Communications |
2 | 0.14 |
Organic Letters |
2 | 0.20 |
Proceedings of the National Academy of Sciences of the United States of America |
1 | 0.03 |
Science |
1 | 0.04 |
Science Translational Medicine |
1 | 1.00 |
The Lancet |
2 | 1.31 |
The Lancet Neurology |
1 | 0.30 |
The Lancet Oncology |
1 | 0.30 |
The New England Journal of Medicine |
2 | 0.66 |
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.